Author

K. Sumiyama

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:imaging· 2 Research Focus:host-pathogen & immune response· 1 Approach:microscopy & imaging analysis· 1 Assay:proteomics· 1

Frequent Co-Authors

K. Terai· 2 shared M. Matsuda· 2 shared A. Millius· 1 shared A. Miyawaki· 1 shared C. Oki· 1 shared D. M. Standley· 1 shared D. Perrin· 1 shared H. Fujishima· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

K. Terai

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Circadian ribosome profiling reveals a role for the Period2 upstream open reading frame in sleep

A. Millius, R. Yamada, H. Fujishima, K. Maeda, D. M. Standley, K. Sumiyama, D. Perrin, H. R. Ueda

This study uses ribosome profiling to show that uORFs in Per2 mRNA regulate translation and sleep in mice.

bioRxiv · Aug 9, 2022 · PreprintCell Biology

A FRET biosensor, SMART, monitors necroptosis in renal tubular epithelial cells in a cisplatin-induced kidney injury model

S. Murai, K. Takakura, K. Sumiyama, K. Moriwaki, K. Terai, S. Komazawa-Sakon, Y. Yamaguchi, T. Mikami, K. Araki, M. Ohmuraya, M. Matsuda, H. Nakano

bioRxiv · Jun 18, 2022Cell Biology

Metastatic Single Tumor Cells Evade NK Cell-mediated Killing by Thrombin-mediated Loss of the Activating Ligand CD155/PVR/Necl-5

H. Ichise, S. Tsukamoto, T. Hirashima, Y. Konishi, C. Oki, S. Tsukiji, S. Iwano, A. Miyawaki, K. Sumiyama, K. Terai, M. Matsuda

The paper shows metastatic tumor cells evade NK cell killing by losing CD155/PVR/Necl-5 via thrombin, allowing survival in lung capillaries.

bioRxiv · Jan 15, 2021Immunology